Abstract | BACKGROUND AND PURPOSE: OBJECTIVES: DESIGN: Multicenter, prospective, randomized, open-label trial with patients studied for up to 6 months. An independent clinical evaluation committee assessing trial outcomes was blinded to patients' treatment assignments. SETTING: PATIENTS: INTERVENTIONS: MEASUREMENTS AND MAIN RESULTS: CONCLUSIONS:
|
Authors | Dennis G Maki, Stephen R Ash, Roland K Winger, Philip Lavin, AZEPTIC Trial Investigators |
Journal | Critical care medicine
(Crit Care Med)
Vol. 39
Issue 4
Pg. 613-20
(Apr 2011)
ISSN: 1530-0293 [Electronic] United States |
PMID | 21200319
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Infective Agents
- Citrates
- Fibrinolytic Agents
- Hemodialysis Solutions
- Parabens
- Sodium Citrate
- Heparin
- methylparaben
- Methylene Blue
- propylparaben
|
Topics |
- Anti-Infective Agents
(therapeutic use)
- Catheter-Related Infections
(prevention & control)
- Citrates
(therapeutic use)
- Female
- Fibrinolytic Agents
(therapeutic use)
- Hemodialysis Solutions
(therapeutic use)
- Heparin
(therapeutic use)
- Humans
- Male
- Methylene Blue
(therapeutic use)
- Middle Aged
- Parabens
(therapeutic use)
- Renal Dialysis
(methods)
- Sodium Citrate
- Treatment Outcome
|